Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Scand J Clin Lab Invest ; 80(4): 327-335, 2020 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-32186407

RESUMO

suPAR is a plasma marker of chronic inflammation, and an elevated suPAR is consistently associated with worse outcome in a variety of clinical conditions. Quantification of suPAR is useful for determining patient risk in triage, but there is no fast automatized method for quick determination of suPAR. We developed and validated a rapid latex particle-enhanced turbidimetric immunoassay for quantification of plasma suPAR on the c502 and the c702 Roche Cobas® 8000 measurment systems. The turbidimetric assay was validated against the suPARnostic® ELISA (ViroGates, Denmark). This validation demonstrates suPAR can be analysed by turbidimetry giving very similar results (<15% difference) compared to the ELISA method and the observed correlations (n = 103) were strong, r > 0.95. Roche Cobas® 8000 instruments demonstrated repeatability and repoducibility, CV % at 3.4-4.1 and 5.7-11.4, respectively. The estimated limit of detection was 1.30 µg/L and 1.31 µg/L for the Cobas® c502 and c702, respectively. Dilution tests showed linearity of suPAR from 1.8 to 26.5 µg/L. The acceptable concentrations of Bilirubin, Intralipid and Hemoglobin, were 350 µmol/L, 3.3 g/L and 1.4 g/L, respectively. suPAR can be quantified reproducibly within 10 min using a turbidimetry assay. This assay is faster than ELISA with similar results, making it suitable for clinical routine analysis.


Assuntos
Automação Laboratorial/normas , Imunoensaio/normas , Nefelometria e Turbidimetria/normas , Receptores de Ativador de Plasminogênio Tipo Uroquinase/sangue , Bilirrubina/sangue , Biomarcadores/sangue , Emulsões , Ensaio de Imunoadsorção Enzimática , Hemoglobinas/metabolismo , Humanos , Inflamação , Limite de Detecção , Fosfolipídeos/sangue , Reprodutibilidade dos Testes , Óleo de Soja/sangue
2.
Lipids ; 40(7): 669-76, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16196417

RESUMO

n-3 PUFA influence immune functioning and may affect the cytokine phenotype during development. To examine whether maternal fish oil supplementation during lactation could modify later immune responses in children, 122 lactating Danish mothers with a fish intake below the population median were randomized to groups supplemented for the first 4 mon of lactation with 4.5 g/d of fish oil (equivalent to 1.5 g/d of n-3 long-chain PUFA) or olive oil. Fifty-three mothers with a fish intake in the highest quartile of the population were also included. The FA composition of erythrocyte membranes was measured at 4 mon and at 2 1/2 yr. Plasma immunoglobulin E (IgE) levels and cytokine production in lipopolysaccharide-stimulated whole-blood cultures were determined at 2 1/2 yr. Erythrocyte n-3 PUFA at 4 mon were higher in infants from the fish oil group compared with the olive oil group (P < 0.001) but were no longer different at 2 1/2 yr. The median production of lipopolysaccharide-induced interferon gamma (IFN-gamma) in the fish oil group was fourfold higher than that in the olive oil group (P = 0.034), whereas interleukin-10 (IL-10) production was similar. The IFN-gamma/IL-10 ratio was twofold higher in the fish oil group (P = 0.019) and was positively correlated with 20:5n-3/20:4n-6 in erythrocytes at 4 mon (P = 0.050). The percentages of atopic children and plasma IgE were not different in the two groups, but the study was not designed to look at atopy. Cytokine responses and erythrocyte FA composition in children of mothers with a high fish intake were intermediate in comparison with those in the randomized groups. Fish oil supplementation during lactation resulted in increased in vitro IFN-gamma production in the children 2 yr after the supplementation was given, which may reflect a faster maturation of the immune system.


Assuntos
Citocinas/biossíntese , Suplementos Nutricionais , Óleos de Peixe/administração & dosagem , Lactação , Mães , Pré-Escolar , Feminino , Humanos , Imunoglobulina E/sangue , Masculino
3.
J Nutr ; 137(4): 1031-6, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17374672

RESUMO

(n-3) PUFA influence immune function in adults and may also affect immune maturation during development. This randomized trial is, to our knowledge, the first to investigate whether fish oil supplementation in late infancy modifies immune responses. The study was a 2 x 2 intervention in 64 healthy Danish infants, who received cow's milk or infant formula alone or with fish oil (FO) (3.4 +/- 1.1 mL/d) from 9 to 12 mo of age. Before and after the intervention, fatty acid composition of erythrocyte membranes, plasma IgE, C-reactive protein, and soluble IL-2 receptor concentrations were measured. TNF-alpha, INF-gamma, and IL-10 concentrations in whole-blood cultures, stimulated for 22 h with LPS+phytohemaglutinin (PHA) or Lactobacillus paracasei, were also determined. IgA was measured in feces when infants were 10 mo of age. FO supplementation effectively raised erythrocyte (n-3) PUFA (P < 0.001), increased L. paracasei-induced INF-gamma (P = 0.05) and tended to reduce LPS+PHA-induced IL-10 (P = 0.08). The FO intervention did not affect any of the other analyzed immune variables. The erythrocyte content of eicosapentanoic acid was negatively associated with LPS+PHA-induced IL-10 (r = -0.38, P = 0.02). Feeding milk rather than formula did not affect cytokine production, but plasma soluble IL-2 receptor concentration was greater in the formula group than in the cow's milk group (P = 0.03). Since the capacity to produce INF-gamma has been proposed as a maturation marker for the immune system in early life, this study suggests a faster immune maturation with FO supplementation with no apparent reduction in immune activation. The implications for later health need further investigation.


Assuntos
Suplementos Nutricionais , Óleos de Peixe/farmacologia , Sistema Imunitário/efeitos dos fármacos , Animais , Ácido Eicosapentaenoico , Eritrócitos/metabolismo , Ácidos Graxos Insaturados/sangue , Feminino , Humanos , Lactente , Fórmulas Infantis , Interferon gama/biossíntese , Interleucina-10/antagonistas & inibidores , Interleucina-10/sangue , Lactobacillus/imunologia , Lipopolissacarídeos/farmacologia , Masculino , Leite , Fito-Hemaglutininas/farmacologia , Receptores de Interleucina-2/sangue , Valores de Referência
4.
J Nutr ; 136(1): 94-9, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16365065

RESUMO

Animal and epidemiologic studies indicate that early nutrition has lasting effects on metabolism and cardiovascular disease risk. In adults, (n-3) long-chain PUFA (LCPUFA) from fish oils improve blood pressure, the lipid profile, and possibly cardiovascular disease mortality. This randomized trial is the first to investigate the effects of fish oil on blood pressure and the lipid profile in infancy. Healthy term 9-mo old infants (n = 83) were randomly assigned to 5 mL fish oil daily or no fish oil for 3 mo and to 2 different milk types. Before and after the intervention, blood pressure was measured with an oscillometric device, and blood was sampled for analysis of erythrocyte fatty acid composition and the plasma lipid profile. This paper examines the effects of the fish oil supplement, with adjustment for the effects of the milk intervention when relevant. The fish oil intervention increased erythrocyte (n-3) LCPUFA content (P < 0.001). At 12 mo, infants administered fish oil had a lower systolic blood pressure [adjusted mean difference (95% CI)] 6.3 mm Hg (0.9, 11.7) (P = 0.02), a 0.51 mmol/L (0.07, 0.95) higher plasma total cholesterol (P = 0.02), and a 0.52 mmol/L (0.02,1.01) higher LDL cholesterol (P = 0.04) than infants not administered fish oil. Plasma triacylglycerol was inversely associated with the erythrocyte content of eicosapentaenoic acid (r = 0.34, P < 0.01), a biomarker of fish oil dose. The observed effects of fish oil are in accordance with findings in adults. The long-term health implications warrant further investigation.


Assuntos
Pressão Sanguínea/efeitos dos fármacos , Óleos de Peixe/farmacologia , Lipídeos/sangue , Dinamarca , Eritrócitos/efeitos dos fármacos , Eritrócitos/metabolismo , Feminino , Humanos , Lactente , Masculino
5.
J Nutr ; 134(5): 1110-3, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15113954

RESUMO

We examined in rats the intestinal absorption of fat from dairy products differing in physiochemical properties. Five dairy products (cream cheese, cream, sour cream, butter, and mixed butter) with minor differences in fatty acid composition were administered by gavage to rats, and lymphatic fat absorption was examined. Absorption was followed for 8 h after administration of 300 mg fat from the dairy products. Administration of cream and sour cream resulted in faster lymphatic fat absorption than cream cheese, butter, and mixed butter, and at 8 h the accumulated absorption of fat was significantly higher. The lymphatic absorption of fat after cream cheese administration was similar to the absorption after butter and mixed butter administration up to the 4-h time point; then it increased to a level between that of rats administered cream or sour cream and butter or mixed butter. Overall, these results demonstrated different lymphatic absorption patterns of fat from dairy products differing in physiochemical properties. Because the fatty acid composition of the dairy products differed only slightly, other factors such as viscosity, type of emulsion, particle size, and likely also protein content may have contributed to the differences in absorption.


Assuntos
Laticínios , Gorduras na Dieta/farmacocinética , Sistema Linfático/metabolismo , Absorção , Animais , Fenômenos Químicos , Físico-Química , Ácidos Graxos/metabolismo , Metabolismo dos Lipídeos , Linfa/metabolismo , Masculino , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA